Product Information
EQUETRO 200 MG CAPSULE is a brand product labeled by Validus Pharmaceuticals LLC, priced at $4.1698 per EA under NDC 30698042112. Its NADAC has been published 300 times since Nov 28, 2013.
FDA first approved this application on Dec 10, 2004.
The High Outlier badge above means this manufacturer's average price in the Carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Validus Pharmaceuticals LLCNDC
30698042112
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBAMAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA021710FDA Approved
12/10/2004
On Market Since
12/10/2004
Pharmacological Classes
Price Statistics
The NADAC for EQUETRO 200 MG CAPSULE has been published 300 times since Nov 28, 2013, and over the history we have for it it has risen 98.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1698 per EA |
|---|---|
| All-time high | $4.1841 (Jun 12, 2024) |
| All-time low | $2.1027 (Nov 28, 2013) |
| 52-week high | $4.1829 |
| 52-week low | $4.1573 |
| Median price | $4.1630 |
| Average price | $3.6097 |
| Largest weekly change | +38.6% (May 21, 2014) |
| Weeks tracked | 300 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EQUETRO 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EQUETRO 200 MG CAPSULE, manufactured by Validus Pharmaceuticals LLC, is $4.1698 per EA (NDC 30698042112), effective Aug 19, 2026.
How has the price of EQUETRO 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EQUETRO 200 MG CAPSULE has risen 98.3%. It has been tracked across 300 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EQUETRO 200 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EQUETRO 200 MG CAPSULE has ranged from a low of $2.1027 (Nov 28, 2013) to a high of $4.1841 (Jun 12, 2024), with a median of $4.1630 per EA.
Are there cheaper alternatives to EQUETRO 200 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE ER 200 MG CAP, is $1.0767 per EA — about 74% below EQUETRO 200 MG CAPSULE.
Who manufactures EQUETRO 200 MG CAPSULE?
EQUETRO 200 MG CAPSULE (NDC 30698042112) is labeled by Validus Pharmaceuticals LLC, and CMS classifies it as a brand product.